Initial feedback from respected source:



Yes i am aware of this but have not had a convincing argument to pursue it.
High doses stop all other antioxidant activity and can cause kidney stones
so this has to be considered.



Love and Healing



Ian



_____

From: Ian Dixon [mailto:iandixon25lr@...]
Sent: 04 April 2006 09:22
To: 'cancercured@yahoogroups.com'; 'melanoma@yahoogroups.com';
'fighttogether@yahoogroups.com'
Subject: FW: [MM-research] High-dose vitamin C as a cancer therapy



I wonder if any trials are being conducted on the combinations of vitamin C
injections along with IL2? Maybe following radiotherapy or some other route
to boost antigens?



Love and Healing



Ian



<http://www.eurekalert.org/pubnews.php> Public release date: 27-Mar-2006

Contact: Marcia Vital
301-496-3583
<http://www.cma.ca/cmaj> Canadian Medical Association Journal


High-dose vitamin C as a cancer therapy


Although early clinical studies conducted by Linus Pauling showed that
high-dose vitamin C, given by intravenous and oral routes, may improve
symptoms and prolong life in patients with terminal cancer, no benefits for
cancer patients were seen when vitamin C therapy was administered orally in
double-blind placebo-controlled studies at the Mayo Clinic. Since then, high
doses of vitamin C have been used only as an "alternative" therapy to
standard cancer treatment. However, recent evidence shows that intravenous
administration of the maximum tolerated dose of vitamin C produces plasma
concentrations about 25 times higher than when the vitamin is administered
orally. At concentrations above 1000 mmol/L -- which can only be achieved by
the intravenous route -- vitamin C is toxic to some cancer cells but not to
normal cells in vitro.

Padayatty and colleagues report on 3 well-documented cases of advanced
cancers, confirmed by histopathologic review, where patients had
unexpectedly long survival times after receiving high-dose intravenous
vitamin C therapy. They assessed the clinical details of each case in
accordance with National Cancer Institute (NCI) Best Case Series guidelines,
and found that the case reports indicate that the role of high-dose
intravenous vitamin C therapy in cancer treatment should be reassessed.





[Non-text portions of this message have been removed]